WebDisclosure WebDisclosure
Basculer en Français
9544 Companies
187974 Keywords
119893 Articles
100419 Press releases
Headlines Articles Press releases Norgine Pharmaceuticals Limited Remove
  1. Home
  2. Companies
  3. Norgine Pharmaceuticals Limited
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 12/17/2025 at 09:10, 2 hours 48 minutes ago

    Norgine Secures Licensing Deal with Vir Biotechnology for Hepatitis Delta Treatment

    Pharmaceuticals Licensing Agreement Norgine Vir Biotechnology Hepatitis Delta
  • BRIEF

    published on 12/17/2025 at 09:10, 2 hours 48 minutes ago

    Norgine conclut un accord de licence avec Vir Biotechnology pour le traitement de l'hépatite delta.

    Médicaments Contrat De Licence Norgine Vir Biotechnology Hépatite Delta
  • PRESS RELEASE

    published on 12/17/2025 at 09:05, 2 hours 53 minutes ago

    Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology

    Norgine enhances hepatology and specialty portfolio by in-licensing Vir Biotechnology's chronic hepatitis delta treatment for Europe, Australia, and New Zealand
    Exclusive Licensing Agreement Specialty Pharmaceuticals Norgine Vir Biotechnology Chronic Hepatitis Delta Treatment
    Logo of Norgine Pharmaceuticals Limited
Accesswire
  • Published on 12/17/2025 at 11:37, 22 minutes ago

    Zentek Subsidiary Albany Graphite Corp. Achieves Near-Theoretical Anode Performance in Battery Suitability Independent Testing

  • Published on 12/17/2025 at 09:05, 2 hours 54 minutes ago

    Over 40% of Adults Struggle to Swallow Pills - BioNxt Targets a Global Adherence Problem with Rapid-Dissolving Thin-Film “Melt-in-Your-Mouth” Therapies

  • Published on 12/17/2025 at 08:00, 3 hours 59 minutes ago

    Pulsar Helium Awards Security Based Compensation

  • Published on 12/16/2025 at 23:20, 12 hours 39 minutes ago

    Tactical Resources Announces Shareholder Approval of Arrangement With Plum Acquisition Corp. III

  • Published on 12/16/2025 at 23:20, 12 hours 39 minutes ago

    GMV Minerals Announces Upsize of Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption

View all ACCESSWIRE
EQS Group
  • Published on 12/17/2025 at 11:25, 33 minutes ago

    Block listing Six Monthly Return

  • Published on 12/17/2025 at 11:12, 47 minutes ago

    EQS-Adhoc: CEOTRONICS receives third SmG call-off worth approximately € 47 million

  • Published on 12/17/2025 at 11:05, 53 minutes ago

    An ambitious project to protect consumer health and promote the excellence of extra virgin olive oil FRANCE OLIVE PRODUCTION - UNAPROL

  • Published on 12/17/2025 at 11:05, 53 minutes ago

    Dstny Celebrates Record-Breaking Year with 10+ International Awards for Cloud Communications Excellence

  • Published on 12/17/2025 at 11:00, 59 minutes ago

    Healthcare specialist SHS Capital invests in a leading German Endoscopy Group

View all EQS
Les Echos
  • Published on 12/16/2025 at 21:45, 14 hours 13 minutes ago

    Mise à disposition du rapport financier annuel

  • Published on 12/16/2025 at 20:10, 15 hours 48 minutes ago

    donation of shares of Seval, member of the Feuillet family concert

  • Published on 12/16/2025 at 20:10, 15 hours 48 minutes ago

    Donation de titres de la société Seval, membre du concert familial Feuillet

  • Published on 12/16/2025 at 18:53, 17 hours 5 minutes ago

    Number of shares and voting rights - November 2025 (In French only)

  • Published on 12/16/2025 at 18:53, 17 hours 5 minutes ago

    Nombre total d'actions et droits de vote - novembre 2025

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy